Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T05:59:15.118Z Has data issue: false hasContentIssue false

9 - Alzheimer's disease

Published online by Cambridge University Press:  12 October 2009

James H. Morris
Affiliation:
John Radcliffe Hospital Oxford, UK
Zsuzsanna Nagy
Affiliation:
Radcliffe Infirmary Oxford, UK
Margaret M. Esiri
Affiliation:
University of Oxford
Virginia M. -Y. Lee
Affiliation:
University of Pennsylvania School of Medicine
John Q. Trojanowski
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

Historical

Alzheimer's disease (AD) is the sole cause of about half of cases of dementia in later life and a significant contributor to cognitive decline in a further quarter (Mirra & Hyman, 2002). It is therefore overwhelmingly the most important factor in what has been called the silent epidemic of dementia that is occurring in societies with ageing populations. Since this includes virtually the entire currently developed world, and because the incidence of AD can be confidently expected to rise in all societies where economic progress leads to increased life expectancy, AD ranks with tuberculosis and malaria in economic and social importance. In part for this reason, an enormous amount of research work has been performed in the last two decades and significant progress has been made in our understanding of the pathophysiology of Alzheimer's disease. It is true that no cure is yet in sight, but progress has been substantial and there are several avenues of research that might generate significant therapeutic advances within the next few years.

No account of the disease would be complete without some mention of the man himself. Amaducci (Amaducci et al., 1986) in an interesting article has described some aspects of the early history of the definition of the disease. Alois Alzheimer in 1907, when he was working in the Laboratory of Anatomy at the Psychiatric and Neurologic Clinic in Munich, described the clinical and pathologic features of the disease, which came to be named for him in a demented patient who had become symptomatic in her early 50s (Alzheimer, 1907). It was Alzheimer, along with his coworkers, Bonfiglio and Perusini, who first described neurofibrillary tangles.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×